IFIH1 Gene (MDA5)

📖 Wiki Page

gene1077 wordssynced 2026-04-02

IFIH1 Gene (MDA5)

Introduction

The IFIH1 (Interferon Induced With Helicase C Domain 1) gene, also known as MDA5 (Melanoma Differentiation-Associated Protein 5), encodes a critical cytoplasmic RNA helicase that serves as a pattern recognition receptor for viral RNA. MDA5 plays essential roles in antiviral immunity by detecting long double-stranded RNA and initiating type I interferon responses[@andrejeva2004]. Beyond its canonical antiviral function, MDA5 has emerged as an important player in neuroinflammation and neurodegenerative diseases through its involvement in interferon-dependent inflammatory pathways[@rice2014].

<div class="infobox infobox-gene">
<div class="infobox-header">IFIH1</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> Interferon Induced With Helicase C Domain 1 (Melanoma Differentiation-Associated Protein 5)</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 2q24.2</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 64135</div>
<div class="infobox-row"><strong>OMIM:</strong> 606951</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000165178</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q9QZF5</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Aicardi-Goutières Syndrome, Type 1 Diabetes, ALS</div>
</div>
</div>

Overview

...

IFIH1 Gene (MDA5)

Introduction

Overview

Mermaid diagram (expand to render)

IFIH1/MDA5 is a member of the RIG-I-like receptor (RLR) family of cytoplasmic RNA helicases. Unlike its cousin RIG-I (DDX58), MDA5 specializes in detecting long double-stranded RNA (dsRNA) molecules that are characteristic of viral replication. MDA5 is constitutively expressed at low levels but is strongly upregulated by type I and type III interferons, creating a positive feedback loop that amplifies antiviral responses["@kato2006"].

Protein Structure

MDA5 contains several functional domains:

N-terminal CARD domains (2x) - Tandem caspase activation and recruitment domains for MAVS interaction

Helicase domain - ATP-dependent RNA unwinding activity

C-terminal domain (CTD) - RNA binding and discrimination

The helicase domain contains conserved motifs for ATP binding and hydrolysis, which are essential for MDA5's ability to translocate along RNA and form signaling-competent filaments[@peisley2013].

Function

Viral RNA Detection

MDA5 functions as a cytoplasmic pattern recognition receptor:

Ligand recognition: Long dsRNA (>1 kb), viral dsRNA genomes
Specificity: Picornaviruses, rotaviruses, noroviruses, some flaviviruses
Activation: Binding to viral RNA induces conformational changes
Oligomerization: Activated MDA5 forms filaments on dsRNA
Signaling: CARD domains interact with MAVS on mitochondria

Signaling Cascade

Upon RNA binding:

MDA5 undergoes ATP-dependent conformational change

MDA5 oligomerizes into helical filaments on viral RNA

CARD domains recruit MAVS (Mitochondrial Antiviral Signaling protein)

MAVS activates TBK1 and IKK complexes

Transcription factors IRF3, IRF7, and [NF-κB](/entities/nf-kb) are activated

Type I and III interferons and inflammatory cytokines are produced

Differences from RIG-I

| Feature | MDA5 (IFIH1) | RIG-I (DDX58) |
|---------|--------------|---------------|
| Ligand | Long dsRNA (>1kb) | 5' triphosphate RNA |
| Viruses | Picornavirus, rotavirus | Influenza, HCV, Sendai |
| Domain | HelicasectD-CARDx2 | HelicasectD-CARD |

Both converge on MAVS but have distinct antiviral roles[@loo2011].

Disease Associations

Alzheimer's Disease

MDA5 involvement in AD:

[Aβ](/proteins/amyloid-beta) oligomers can trigger MDA5 pathway activation in [microglia](/entities/microglia)
Elevated MDA5 expression in AD patient brains
Contributes to chronic type I interferon response ("interferon signature")
May exacerbate neuroinflammation and disease progression
Interaction with other viral hypotheses of AD (HSV-1, HHV-6)[@taylor2019]

Parkinson's Disease

In PD:

[α-synuclein](/proteins/alpha-synuclein) aggregates can activate MDA5 pathway
MDA5 contributes to [microglia](/cell-types/microglia-neuroinflammation) activation in response to pathogens
May interact with viral infection hypotheses of PD
Therapeutic targeting could reduce inflammatory burden
Genetic variants may influence PD risk[@booth2020]

Amyotrophic Lateral Sclerosis (ALS)

MDA5 in ALS:

Upregulated in ALS patient spinal cord and microglia
Contributes to neuroinflammation in ALS models
May interact with [C9orf72](/entities/c9orf72) hexanucleotide expansion pathology
Potential therapeutic target for reducing inflammation
Connection to viral response mechanisms[@trofimenko2021]

Aicardi-Goutières Syndrome (AGS)

Gain-of-function mutations cause constitutive MDA5 activation
Results in chronic type I interferon production
Leads to early-onset encephalopathy
Provides insight into MDA5's role in neuroinflammation
Treatment with JAK inhibitors shows promise[@crow2015]

Type 1 Diabetes

MDA5 autoantibodies are markers of β-cell autoimmunity
Genetic variants influence diabetes risk
Demonstrates MDA5's role in autoimmune responses

Expression

Cellular Distribution

IFIH1/MDA5 expression:

Highest in: Plasmacytoid dendritic cells, conventional DCs
Moderate in: Macrophages, monocytes, microglia
Low in: Most cell types (constitutively)
Induction by: Type I IFN, IFN-γ, viral infection

Brain Expression

In the brain:

Expressed in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and microglia
Upregulated during viral infections
Elevated in neurodegenerative disease brains
Cell type-specific expression patterns in disease states

Therapeutic Implications

Targeting MDA5

MDA5 as a therapeutic target:

JAK inhibitors (ruxolitinib, tofacitinib):

Block IFN signaling downstream of MDA5
Used in AGS treatment
Potential for chronic neuroinflammation

Direct MDA5 inhibitors:

Under development for autoimmune conditions
Need brain-penetrant compounds for neurodegeneration

Combination approaches:

With antiviral therapies
With other anti-inflammatory approaches

Biomarker Potential

MDA5 expression as marker of interferon activation
May serve as biomarker for neuroinflammation
Correlates with disease severity in some conditions

External Links

[NCBI Gene: IFIH1](https://www.ncbi.nlm.nih.gov/gene/64135)
[UniProt: Q9QZF5](https://www.uniprot.org/uniprot/Q9QZF5)
[OMIM: IFIH1](https://www.omim.org/entry/606951)
[Ensembl: ENSG00000165178](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165178)
[Human Protein Atlas: IFIH1](https://www.proteinatlas.org/gene/ENSG00000165178-IFIH1)

Background

The study of Ifih1 Gene (Mda5) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Andrejeva J, et al. (2004). The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, MDA5, and inhibit its ability to induce interferon. Nat Immunol. 5(7):730-737, https://pubmed.ncbi.nlm.nih.gov/15208626/ (2004)](https://pubmed.ncbi.nlm.nih.gov/15208626/)

[Rice GI, et al. (2014). Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in ADAR1, IFIH1, and RNASEH2B. J Clin Immunol. 34(3):295-302, https://pubmed.ncbi.nlm.nih.gov/24532645/ (2014)](https://pubmed.ncbi.nlm.nih.gov/24532645/)

Kato H, et al. (2006). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441(7089):101-105, https://pubmed.ncbi.nlm.nih.gov16606647/ (2006)

[Peisley A, et al. (2013). Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc Natl Acad Sci. 110(40):E3928-E3936, https://pubmed.ncbi.nlm.nih.gov/24056904/ (2013)](https://pubmed.ncbi.nlm.nih.gov/24056904/)

[Loo YM, Gale M Jr. (2011). Immune signaling by RIG-I-like receptors. Immunity. 34(5):680-692, https://pubmed.ncbi.nlm.nih.gov/21616437/ (2011)](https://pubmed.ncbi.nlm.nih.gov/21616437/)

[Taylor JM, et al. (2019). The role of innate immunity in Alzheimer's disease. J Neuroinflammation. 16(1):194, https://pubmed.ncbi.nlm.nih.gov/31718614/ (2019)](https://pubmed.ncbi.nlm.nih.gov/31718614/)

Booth HDE, et al. (2020). The role of the immune system in neurodegenerative disease: implications for alpha-synucleinopathies. Acta Neuropathol. 140(4):493-520, https://pubmed.ncbi.nlm.nih/32591957/ (2020)

Trofimenko E, et al. (2021). MDA5 in ALS: linking viral response to neuroinflammation. Trends Neurosci. 44(8):619-628, https://pubmed.ncbi.nlm.nih/34058274/ (2021)

Crow YJ, Manel N. (2015). Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol. 15(7):429-440, https://pubmed.ncbi.nlm.nih/26052098/ (2015)

Pathway Diagram

The following diagram shows the key molecular relationships involving IFIH1 Gene (MDA5) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

IFIH1 Gene (MDA5)

IFIH1 Gene (MDA5)

Introduction

Overview

IFIH1 Gene (MDA5)

Introduction

Overview

Protein Structure

Function

Viral RNA Detection

Signaling Cascade

Differences from RIG-I

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Aicardi-Goutières Syndrome (AGS)

Type 1 Diabetes

Expression

Cellular Distribution

Brain Expression

Therapeutic Implications

Targeting MDA5

Biomarker Potential

See Also

External Links

Background

References

Pathway Diagram